DRKS00025864
Recruiting
Not Applicable
A pilot study to investigate the immunological regulation of preeclampsia
Carl von Ossietzky Universität Oldenburg/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe0 sites200 target enrollmentJanuary 18, 2022
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- O14
- Sponsor
- Carl von Ossietzky Universität Oldenburg/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •pregnancy with one fetus after the 20th pregnancy week
Exclusion Criteria
- •fetus has genetic defects like trisomy; multiple pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Acupuncture and reproductive health outcomes: building evidence in an integrated care setting.Immune System HealthReproductive HealthReproductive Health and Childbirth - Fertility including in vitro fertilisationInflammatory and Immune System - Normal development and function of the immune systemAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12609000923268niversity of Western Sydney40
Active, not recruiting
Phase 1
A study on the anti-inflammatory effects of azithromycin in tuberculosisEUCTR2017-001929-40-NLniversity Medical Center Groningen24
Recruiting
Phase 2
A prospective, randomized pilot study of the immunomodulatory effects of azithromycin in adults with pulmonary tuberculosisNL-OMON47928niversitair Medisch Centrum Groningen24
Completed
Not Applicable
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
Completed
Not Applicable
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60